FOA Search

This funding opportunity aims to accelerate the establishment of effective and reliable biomarkers for Alzheimer's disease (AD) and AD-related dementias (ADRD), supporting analytical and/or clinical validation of biomarkers with rigor consistent with FDA regulatory pathways. The goal is to enable their use in therapy and medical product discovery, clinical development, and clinical practice.

The New Investigator Gateway Awards for Collaborative T1D Research (R03) is a funding opportunity from the National Institutes of Health (NIH), specifically through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Office of The Director (OD). The program aims to support a robust pipeline of innovative projects and new investigators in type 1 diabetes (T1D) research, focusing on understanding T1D mechanisms, prevention, treatment, and cure. Awardees will be embedded within large, established research consortia such as HIRN, TrialNet, TEDDY, DFC, and CaRe-T1D to promote collaboration, networking, and career advancement. Clinical trials are not allowed for this opportunity. Applicants must target research topics aligned with the scientific priorities of these consortia and address key barriers in T1D research.

This NIH funding opportunity seeks to support collaborative research that leverages biosamples and/or data from type 1 diabetes clinical studies or trials to advance understanding of the disease's etiology and pathogenesis. The ultimate goal is to uncover critical disease mechanisms that help delay or prevent type 1 diabetes. Projects should utilize samples or data from rigorously characterized clinical resources such as DPT-1, TrialNet, or TEDDY, ensuring documented access consistent with NIH sharing policies. Topics of interest include biomarkers, environmental triggers, autoimmunity, mechanistic studies using multi-omics, immune activity at various disease stages, therapeutic responses (especially immune modulation), age effects, and comorbid autoimmune conditions. Non-responsive projects include those proposing use of animal models, clinical trials with efficacy endpoints, or any use of restricted samples not permitting open data/publication in accordance with NIH policy.

The New Investigator Gateway Award in Type 1 Diabetes (T1D) Research provides support for innovative preliminary research projects by new and early stage investigators. This program embeds awardees within major collaborative consortia, offering them opportunities to network, deepen understanding of key questions in T1D, and form lasting research collaborations to propel their careers forward. The initiative is expected to benefit both investigators and collaborative networks by bringing in new perspectives, ideas, and fostering a robust pipeline of talent in T1D research. Clinical trials are not permitted under this R03 mechanism.

This Notice of Funding Opportunity (NOFO) invites applications for studies of type 1 diabetes etiology and pathogenesis using data and biosamples from clinical trials and studies. The goal is to fund investigative teams collaborating to answer important questions about disease mechanisms leading to improved prevention of type 1 diabetes. Clinical trials are not allowed under this funding opportunity.

The International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) provides 3 to 5 years of support and protected time to advanced postdoctoral U.S. research scientists and recently-appointed junior faculty. The award aims to facilitate mentored research career development in a low- or middle-income country (LMIC), fostering the transition to an independent global health research career focusing on the LMIC's health priorities. The opportunity is designed for candidates proposing to lead an independent clinical trial, feasibility study, or ancillary trial, with strong mentoring support from both U.S. and LMIC institutions. Applicants must develop impactful research addressing scientific needs of LMICs, develop research skills, and fulfill robust institutional and mentor commitment requirements.

The International Research Scientist Development Award (IRSDA) (K01) provides support and protected time (3-5 years) to advanced postdoctoral U.S. research scientists and recently appointed junior faculty for an intensive, mentored research career development experience in a low- or middle-income country (LMIC), as defined by the World Bank. The goal is to help researchers develop independently funded research careers focused on global health. Applicants must propose career development activities and a research project relevant to the health priorities of the LMIC under the mentorship of both LMIC and U.S. mentors. Independent Clinical Trials are not allowed.

This funding opportunity aims to promote research investigating protective and pathogenic mechanisms at the intersection of mitochondrial function and aging, focusing on the context of HIV infection and exposure to addictive substances. The goal is to generate foundational knowledge that can be leveraged to develop targeted therapies and improve outcomes for people aging with HIV, substance use, and addiction.

This funding opportunity, issued by the National Institutes of Health (NIH), aims to promote research investigating protective and pathogenic mechanisms at the nexus of mitochondrial function and aging, specifically in the context of HIV infection and exposure to addictive substances. The goal is to generate foundational knowledge that could be leveraged to develop targeted therapies and improve health outcomes for people aging with HIV, substance use, and addiction. Clinical trials are not allowed under this R01 mechanism.

The AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Scientist Career Development Award (K08) provides an intensive, mentored research career development experience in comparative effectiveness research (CER) methods as applied to patient-centered outcomes research (PCOR). This program is designed to support qualified individuals and aims to improve healthcare outcomes based on patient perspectives.

The Mentored Career Transition Award for NIMH Intramural Fellows (K22) is a two-phase, mentored career development program aimed at facilitating the timely transition of qualified postdoctoral fellows in the NIMH Division of Intramural Programs (DIRP) from intramural postdoctoral research positions to extramural, academic tenure-track or equivalent faculty positions at eligible U.S. institutions. Both phases of the award involve mentorship, and research support is provided during the extramural phase to launch competitive, independent research programs. Applicants must propose to serve as lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial as part of their research and career development.

This funding opportunity supports research and training related to hazardous substances under the Superfund Hazardous Substance Program (P42 Clinical Trial Optional). Sponsored by the National Institute of Environmental Health Sciences (NIEHS) at NIH, this grant focuses on the assessment, evaluation, and treatment of hazardous substances. The program is governed by NIEHS legislative authority and Section 311(a)(3) of SARA, emphasizing both basic research and education to address hazardous waste issues.

The Mentored Career Transition Award for NIMH Intramural Fellows (K22) is a two-phase, mentored career development award program designed to facilitate a timely transition of qualified postdoctoral fellows in the NIMH Division of Intramural Programs (DIRP) from intramural postdoctoral research positions to extramural academic tenure-track or equivalent faculty positions at eligible U.S. institutions. Both phases are mentored, and the award supports the extramural phase to help launch competitive, independent research programs. This FOA does not allow applicants to lead independent clinical trials, clinical trial feasibility studies, or ancillary studies to clinical trials, but does allow research experience in clinical trials if the trial is led by a mentor or co-mentor.

The AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01) provides support to qualified individuals for an intensive, mentored research career development experience. The program focuses on comparative effectiveness research (CER) methods as applied to patient-centered outcomes research (PCOR), helping researchers develop the skills necessary for a successful independent research career.

This Notice of Funding Opportunity (NOFO) invites applications to use the NIH INCLUDE Project (Investigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) resources to generate a large volume of integrated genomic and multi-omics data to facilitate discovery of molecular mechanisms underlying health conditions related to Down syndrome. Applicants may propose omics assays of existing biospecimens from individuals with Down syndrome and controls, utilizing techniques such as whole genome sequencing (short-read and long-read), exome, epigenome, transcriptome sequencing, proteomics, metabolomics, single-cell RNA sequencing, and ATAC sequencing when justified. All generated omics and phenotypic data will be deposited in a public INCLUDE Project controlled-access database for research community sharing. No direct funding is provided to applicants under this NOFO, but successful applicants gain access to NIH resources for data generation. Clinical trials are not permitted.

This funding opportunity, issued by the National Institutes of Health (NIH), Department of Health and Human Services, aims to support small business concerns (SBCs) in developing technologies for commercialization to address health-related social needs impacting substance use disorders (SUD), specifically excluding alcohol use disorder.

The HIV Vaccine Research and Design (HIVRAD) Program supports multi-component, multi-disciplinary projects that investigate scientific questions related to AIDS prophylactic vaccine discovery research. The program allows for extensive evaluation of vaccine concepts in non-human primate models. The funding instrument is a grant, categorized as discretionary, and the program is administered by the U.S. Department of Health and Human Services through the National Institutes of Health (NIH).

This funding opportunity supports applications from small business concerns (SBCs) to develop technologies for commercialization that address health-related social needs impacting substance use disorders (SUD), excluding alcohol use disorder. Funded projects should create innovative solutions or products to improve the circumstances contributing to SUDs. The funding mechanism is the R43/R44 grant with clinical trial participation optional. Applications must be submitted via Grants.gov, and project aims must exclude alcohol use disorder as a focus.

This Small Research Grant (R03) supports meritorious projects that seek to improve the prevention, diagnosis, treatment, and care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The program encourages the next generation of researchers to pursue careers in AD/ADRD research and stimulates established researchers without a major AD/ADRD award to conduct pilot studies for innovative research based on their expertise. The funding supports a wide array of topics within AD/ADRD to advance scientific understanding and interventions.

This funding opportunity, sponsored by the National Institutes of Health (NIH), aims to support doctoral candidates engaged in high-priority areas of maternal and child health by facilitating dissertation research that leverages the Environmental influences on Child Health Outcomes (ECHO) program's large, longitudinal datasets. The ECHO DASH data repository contains de-identified data from over 71,000 maternal and child participants across the U.S., focusing on environmental exposures and key pediatric outcomes such as pre-, peri-, and postnatal health, airway outcomes, obesity, neurodevelopment, and positive health. This grant enables doctoral students to analyze these data, advancing research on early environmental exposures and child health.

This funding opportunity, issued by the National Institutes of Health, supports the advancement of research and training in high-priority areas of child health using data from the Environmental influences on Child Health Outcomes (ECHO) Cohort. Utilizing ECHO's large longitudinal dataset housed within the NICHD Data and Specimen Hub (DASH), postdoctoral fellows from relevant scientific communities are invited to analyze early environmental exposures and child health outcomes. The ECHO DASH resource contains de-identified data from more than 71,000 maternal and child participants across the U.S., focusing on prenatal and child environmental exposures and five primary pediatric outcome areas: pre-, peri-, and postnatal outcomes; upper and lower airway outcomes; obesity and its consequences; neurodevelopment; and positive health. The fellowship is designed to facilitate the entry of promising new investigators into this critical field and to enhance the talent pool in child health research.

This funding opportunity, issued by the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services, aims to support data mining of single cell datasets to identify cell types, transcripts, enhancers, or transcriptional networks involved in HIV/antiretroviral therapy (ART) or Substance Use Disorder (SUD)-related molecular responses. Additionally, it will fund functional validation studies, such as epigenomic or transcriptomic manipulation and high throughput secondary screening, to establish the biological role of the identified targets in these contexts. Clinical trials are not allowed under this R21 initiative. The funding instrument is a discretionary grant supporting projects in the areas of education and health.

This funding opportunity, sponsored by the National Institutes of Health (NIH), supports data mining of single cell data sets to identify cell types, transcripts, enhancers, or transcriptional networks integral to HIV/antiretroviral therapy (ART) or Substance Use Disorder (SUD) molecular responses. Additionally, it funds functional validation studies, such as epigenomic or transcriptomic manipulation and high throughput secondary screening, to confirm or refute the biological role of these identified molecular features in HIV/ART and SUD responses. Clinical trials are not allowed under this R01 funding mechanism.

This funding opportunity, provided by the National Institutes of Health (NIH), encourages exploratory and developmental research applications focused on the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools designed specifically for low- and middle-income countries (LMICs). The primary aim is to catalyze innovation using multidisciplinary research to address global health problems, develop an evidence base for mHealth technologies that improve clinical and public health outcomes, and build mHealth research capacity in LMICs. Applicants are required to include partnerships between at least one U.S. institution and one LMIC institution.

This Notice of Funding Opportunity (NOFO) will support the ACTION (Academic Career Transition Initiative for Opportunities in Neuroscience) Potential F99/K00 award. The program aims to support skilled neuroscience graduate students performing research aligned with the NIH Blueprint for Neuroscience Research and/or BRAIN Initiative. The two-phase award facilitates completion of doctoral dissertations and smooth transitions to strong neuroscience postdoctoral positions, providing support for career development toward becoming independent neuroscience researchers. This NOFO utilizes the F99/K00 activity code. As of now, it is a forecasted opportunity and applications are not currently being accepted; the notice is provided to allow sufficient time for collaboration and project planning.

This opportunity, issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH), aims to support high-priority HIV research focused on infants, children, youth, young adults (AYA), and maternal populations. The initiative will establish a clinical trials network dedicated exclusively to pediatric and maternal HIV cases, conducting rigorously designed collaborative clinical trials in partnership with site consortia. Research areas include HIV and related comorbidities and coinfections. Collaborative projects combining expertise in chronic and infectious diseases, pediatrics, adolescent medicine, laboratory innovation, and cost-effectiveness are encouraged. The funding mechanism will be a cooperative agreement (UM2 activity code). Applications are not yet being solicited; this is a preliminary notice to allow time for consortium-building and project development.

The Ellison Education Grant - Professional Learning supports K-12 public or charter school educators in Washington State in developing and participating in self-designed, collaborative professional learning plans or academic enrichment projects. Grants are designed to empower innovative and inspirational teachers to address both student and educator learning needs through evidence-based, research-informed practices. Applicants are required to propose a detailed plan including objectives, timeline, budget, and assessment approach. Funding is available for teams of educators, and awards aim to support professional learning experiences or student enrichment curriculum.

The Ellison Education Grants, offered by the Ellison Foundation, support K-12 public and charter school teachers in Washington State to develop academic enrichment curriculum for students or undertake professional learning experiences to improve instructional practice. Grants range from $1,000 to $10,000 and are intended to empower effective, innovative, and inspirational educators during the 2026-2027 school year. Applicants must submit proposals outlining their project goals, expected outcomes, and budgets. Both individual and teams of teachers may apply for Academic Enrichment grants, whereas Professional Learning grants are reserved for teams. Recipients are expected to collaborate and share ideas with the Foundation and other educators.

The New Horizons for Seniors Program (NHSP), delivered by Employment and Social Development Canada (ESDC), aims to ensure that seniors can benefit from and contribute to quality of life in their communities. This program supports projects that promote volunteerism among seniors, expand awareness of elder abuse (including financial abuse), support social participation and inclusion, and provide capital assistance for new and existing community projects and programs for seniors. The recipient organization for this funding is Vision Saint Andrews Incorporated, a not-for-profit located in St Andrews, New Brunswick, Canada.

ROSES 2025: C.2 Solar System Science is a NASA Headquarters Science Mission Directorate program element supporting research and technology advancing Solar System Science under the Planetary Science Division. It forms part of the annual NASA-wide Research Opportunities in Space and Earth Sciences (ROSES) omnibus announcement, which covers a broad spectrum of basic and applied research in space and Earth sciences. This program element specifically seeks proposals for research related to planetary science and planetary exploration. Proposals may be submitted at any time before the final closing date and must follow the ROSES-25 rules and NASA's Grant and Cooperative Agreement Manual (GCAM).

This opportunity supports rapid response and novel research in Earth Science as part of NASA's omnibus Research Opportunities in Space and Earth Sciences (ROSES) 2025. Managed by NASA Headquarters under the Science Mission Directorate (SMD), this program element welcomes a wide range of basic and applied research and technology projects. Awards are primarily made as grants or cooperative agreements, supporting extramural researchers in government, private, for-profit, not-for-profit, domestic, and foreign organizations (with specific caveats for non-U.S. institutions and no-exchange-of-funds policies). Proposals may be submitted at any time up to March 31, 2026, and are evaluated under the rules specified in the current Grants and Cooperative Agreement Manual (GCAM). Detailed instructions, eligibility requirements, and proposal forms are specified in the program element documentation found on NSPIRES.

This program element is part of NASA's Research Opportunities in Space and Earth Sciences (ROSES) 2025 omnibus solicitation. It supports basic and applied research and technology development in Solar System Science under the Science Mission Directorate (SMD). The solicitation encompasses a wide range of research and technology topics, with proposals accepted at any time until the indicated deadline. Awards within this element may be made as grants, cooperative agreements, or contracts, with most extramural awards being grants. Typical periods of performance are three years, but some projects may allow up to five years. Key details, program element text, and associated instructions are available through NSPIRES and solicitation tables.

ROSES 2025: A.10 INNOVATE is a program element under NASA’s Research Opportunities in Space and Earth Sciences (ROSES) 2025 solicitation. This opportunity is administered by NASA Headquarters and supports a wide range of basic and applied research and technology activities aligned with the Science Mission Directorate. Proposals may be submitted at any time until March 31, 2026. The typical award period is three years, though some projects may run for up to five years. Awards may take the form of grants, cooperative agreements, or contracts, with most being grants. The submission process primarily uses the NSPIRES portal, though Grants.gov may be allowed under certain conditions. Teaming arrangements are generally unrestricted, and both U.S. and (in some cases) foreign organizations may participate, subject to specified guidelines.

This funding opportunity is part of NASA's ROSES 2025 omnibus Research Announcement, supporting Rapid Response and Novel Research in Earth Science. It invites proposals for a wide spectrum of basic and applied research and technology activities relevant to Earth Sciences as defined by NASA's Science Mission Directorate. As one of approximately 35 distinct program elements under the overarching ROSES-2025 solicitation (NNH25ZDA001N), this opportunity aims to advance both foundational and innovative Earth science investigations. Specific proposal requirements are outlined for this element (A.4), with official documents and guidance available through the NSPIRES portal.

This funding opportunity, provided by the Three Guineas Trust (UK charity number 1059652), supports holiday play and activity schemes for autistic children and young people, including their siblings, during school holidays in the UK. Grants are intended to cover part of the operational costs for autistic-specific activity programmes or additional costs for personalized support enabling participation in other schemes. Funding aims to promote autonomy, liberty, and human rights for autistic and neurodivergent individuals, and may also support social skills and family support projects. Residential activities, capital projects, pure research, projects using Applied Behavioural Analysis or other coercive methods, app/software development, and grants to individuals, schools, or organizations not operating in the UK are not eligible. The 2026 round will focus even more strongly on autistic-specific holiday schemes, running in spring 2026, with application information available mid-January 2026.

This funding opportunity, provided by the National Institutes of Health (NIH), supports the advancement of non-hormonal contraceptive and reproductive health product development. The Chemical Synthesis and Optimization Facility offers state-of-the-art preclinical services, including protein generation, X-ray crystallography, high throughput screening, structure activity relationship studies, hit-to-lead generation, and drug metabolism. The long-term goal is to facilitate the development of preclinical candidates for Investigational Device Exemption (IDE) or Investigational New Drug (IND) studies, leading to safe therapeutic options in contraception and reproductive health.

This forecasted Notice of Funding Opportunity (NOFO) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, solicits applications for research on ancillary studies that leverage resources from ongoing parent clinical studies, such as patient cohorts, infrastructure, data, and biological samples. While parent studies may fall outside the NIAMS mission, ancillary studies supported through this mechanism must align with the NIAMS mission, which is focused on arthritis, musculoskeletal, and skin diseases. Clinical trials are not permitted under this opportunity. Collaborative research approaches leveraging clinical research expertise are encouraged. This is a pre-announcement: applications are not currently being solicited. The forecast provides lead time for potential applicants to develop relevant collaborations and projects.

This funding opportunity from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), invites applications for ancillary studies that leverage the resources (such as well-characterized patient cohorts, infrastructure, data, and biological samples) of ongoing parent clinical studies. While the parent studies may be outside the NIAMS mission, the proposed ancillary study must align with and address the NIAMS mission. R01 clinical trial applications are explicitly not allowed. The opportunity encourages collaborative investigations and welcomes investigators with expertise in NIAMS-related diseases and conditions.

The Findable Accessible Interoperable Reusable Open Science (FAIROS) Program supports a broad range of transformative open science activities. These activities include advancing sustainable multi-disciplinary FAIR research data management (RDM) and open science capabilities, piloting new models of scientific communication and publication, developing FAIROS data portals and research data commons, and lowering barriers to accessing, curating, managing, and sharing data across disciplinary domains. Proposals must select one of two tracks: Disciplinary Improvements, focused on specific scientific communities, or Cross-Cutting Improvements, which apply across scientific fields. The program encourages collaborative, community-oriented, multidisciplinary projects involving one or more institutions. It supports innovation across the cyberinfrastructure ecosystem to address key issues in accessibility, data curation, research data management, discoverability, reliability, reproducibility, preservation, and sustainability of research products including data, software, and code. The program is undertaken in support of the US NSF Public Access Initiative.

The Predoctoral to Postdoctoral Transition Award (Parent F99/K00) is designed to support and retain promising graduate students as they complete their doctoral research training and transition into mentored postdoctoral career development opportunities in research areas relevant to the missions of participating NIH Institutes and Centers. This Notice of Funding Opportunity is issued by the National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services.

This funding opportunity, offered by the Dutch Research Council (NWO) as part of the Knowledge and Innovation Covenant (KIC) 2024-2027, supports interdisciplinary research on the development and adoption of Digital Twins. The call focuses on advancing Digital Twins that enable public and private organizations to deeply understand and optimize their processes through simulation and autonomous adjustment based on real-time data. The program encourages applications from public-private consortia, aiming to enhance productivity and decision-making in both the industry and public sector. The total budget allocated for this call is €7,000,000. The call is currently in preparation, and details may be subject to change until the official launch and publication of final call texts.

This funding opportunity, led by the National Institute of Nursing Research (NINR) and other NIH Institutes, Centers, and Offices (ICOs), aims to support rigorous research examining the social determinants of health (SDOH) with the goal of improving nutrition-related health outcomes and reducing health disparities across the entire lifespan. The initiative is grounded in nursing science and seeks to accelerate progress in narrowing critical gaps in nutritional health from prenatal stages to older adults.

This opportunity, released by the National Institute of Nursing Research (NINR) of the NIH, seeks to foster multi-disciplinary and multisectoral research addressing the complex interplay between school environments, education, health services, and the surrounding ecosystem. The goal is to fill critical research gaps and advance interventions that will optimize educational and health outcomes for all youth. This discretionary grant is intended to leverage nursing research to create healthier school environments nationwide.

This opportunity, led by the National Institute of Nursing Research (NINR) at the National Institutes of Health (NIH), invites applications to support activities that provide career mentoring and hands-on, mentored research experiences. The goal is to promote career advancement among nurse scientists and to expand the population of nurse scientists with NIH-funded research programs. This funding opportunity falls under the Health category and specifically supports nursing research.

This funding opportunity, led by the National Institute of Nursing Research (NINR) and other NIH Institutes, Centers, and Offices (ICOs), seeks to support research that expands the evidence base for approaches addressing the context of people’s lives and living conditions to prevent, treat, and eliminate violence against women (VAW), ultimately improving health outcomes. Projects may employ a range of research designs and methods designed to interrupt the cycle of violence against women through targeted interventions.

This funding opportunity supports projects aiming to assess the biological influence on ocean carbon storage via a multiple model approach, as part of the BIO-Carbon and NASA EXPORTS research programs. Projects are expected to address key questions on the role of marine life in carbon uptake, storage, vertical transfer, and uncertainties in predictive modeling up to 2100. The program supports robust, collaborative UK-US research to improve models and predictions of future ocean carbon storage, delivering scientific understanding and frameworks to inform climate and environmental policy.

This is a pre-announcement for a major funding opportunity supported by the Natural Environment Research Council (NERC, UKRI) and in collaboration with NASA. The call invites applications for projects developing novel modelling approaches to understand biological processes influencing ocean carbon storage and to provide robust predictions of future changes. Projects should focus on how marine life impacts carbon uptake, transformation, and storage in the ocean, particularly addressing knowledge gaps in vertical transfer efficiency and ecosystem respiration. The funding encourages UK-US collaborative research teams, with leads based in the UK (NERC-eligible institutions) and US members supported by NASA. The maximum award for the UK component is £312,500 at 80% FEC, and for the US component, up to $1,000,000. The total funding available is £1,000,000. The programme duration is up to 24 months. Applications will be submitted through the UKRI Funding Service, and the scheme aims to produce improved global model parameterisations and emergent constraints for coupled ocean-atmosphere models.

The LPS Qubit Collaboratory (LQC), led by the U.S. Army Research Office (ARO) in partnership with NSA’s Laboratory for Physical Science (LPS), is seeking proposals under its Broad Agency Announcement. The mission of LQC is to pursue disruptive research and technologies focused on qubit development for quantum computing and sensing, foster deep collaborations addressing long-term challenges in quantum information science and technology, and develop the quantum workforce through research experiences at LPS and partner institutions. Proposals are solicited in three categories: Incubator (smaller, proof-of-concept or concept development initiatives for individuals or small teams), Collaboratory (significant collaborations among academia, industry, and government labs to tackle fundamental problems in qubit development over 1-3 years), and Quantum Computing Research (QuaCR) Fellowships (supporting U.S. citizen graduate and postdoctoral researchers in quantum information processing and related areas). The opportunity provides a mechanism for collaborative research and aims to advance foundational and transformative research in quantum technologies that address key scientific and technical hurdles.

This funding opportunity aims to renew the NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA). The initiative will support two collaborative research consortia through open competition to study brain-body homeostatic dysregulation that promotes and perpetuates excessive alcohol drinking and related Alcohol Use Disorder (AUD) phenotypes. The program encourages hypothesis-centered research on interactions between alcohol and other relevant causal influences, particularly focusing on trajectories from initial exposure to pathological drinking, with the goal of identifying translatable markers and mechanisms to facilitate future prevention and intervention of conditions associated with alcohol misuse. Innovation is central, with investigators encouraged to utilize advanced tools from the BRAIN Initiative, NIH Common Fund, and other sources, to analyze brain structure and function at multiple spatial and temporal scales and peripheral influences. The initiative emphasizes integration across biological scales, standardization, replication, collaboration across sites, sharing of resources, standardized protocols, and cross-species translation.

This opportunity aims to renew the NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA) by supporting two collaborative research consortia to study brain-body homeostatic dysregulation promoting excessive alcohol consumption and related Alcohol Use Disorder (AUD) phenotypes. The focus is on understanding trajectories from initial alcohol exposure to pathological drinking, identifying translatable markers and mechanisms for prevention and intervention to reduce the chronic conditions tied to alcohol misuse, including AUD. The initiative encourages the use of advanced neurotechnologies from sources such as the BRAIN Initiative, examining brain structure and function at various spatial and temporal scales, and identifying peripheral influences on brain function associated with excessive drinking. Efforts to promote rigor, reproducibility, and integration include standardized neurofunctional measures, replication across sites, and collaboration in multisite consortia.